340B Program

The 340B program allows qualifying safety net providers that serve a high proportion of low-income, uninsured, and underinsured patients to purchase outpatient drugs at a discounted price from pharmaceutical manufacturers. GNYHA continues to educate lawmakers on the importance of the 340B program, and will keep members informed on program updates.

8 Items in 340B Program
MACs to Reprocess Medicare 2022 340B Drug Claims Upon Request; Action Required
October 19, 2022
News
Finance & Insurance Medicare 340B Program
Finance Icon
HHS to Adjust 340B Rates for Remainder of 2022 Following Court Ruling
October 6, 2022
News
Finance & Insurance Medicare 340B Program
Finance Icon
Supreme Court Rules in Favor of AHA on 340B Rate Cut
June 16, 2022
News
Finance & Insurance Medicare 340B Program
Finance Icon
HRSA Notifies 340B Eligibility Exceptions
March 24, 2022
News
Finance & Insurance Medicare 340B Program
Finance Icon
SCOTUS to Hear AHA Challenge to 340B Rate Cut, Declines to Hear Challenge to Site-Neutral Cut
July 2, 2021
News
Finance & Insurance Medicare 340B Program
Finance Icon
CMS Proposes Additional 340B Drug Cuts, Makes Certain Telehealth Provisions Permanent, and Responds to Allina Ruling
August 6, 2020
News
Finance & Insurance Medicare 340B Program
Finance Icon
Proposed Collection of 340B Acquisition Cost Data Under OMB Review
February 18, 2020
News
Finance & Insurance Medicare 340B Program
Finance Icon
GAO Recommends Increased Oversight of 340B Program
February 18, 2020
News
Finance & Insurance Medicare 340B Program
Finance Icon